Roivant Sciences (ROIV) Net Margin (2020 - 2024)
Roivant Sciences (ROIV) posted Net Margin of 1737.12% for Q4 2024, up 280.43% on a QoQ basis from 962.75% in Q3 2024, and up 269369.0% year-over-year from N/an in Q1 2024.
Roivant Sciences (ROIV) Net Margin (2020 - 2024) Analysis & Trends
Roivant Sciences' Net Margin history runs 5 years deep, the most recent figure standing at 1737.12% for Q4 2024.
- Quarterly Net Margin rose 269369.0% year-over-year to 1737.12% in Q4 2024, while the trailing twelve-month figure through Sep 2025 was 1256.56% (up 171034.0% YoY) and the FY2025 annual result came in at 1284.5%, up 224787.0% from the prior year.
- Net Margin was 1737.12% for Q4 2024 at Roivant Sciences, up from 962.75% in the prior quarter.
- Across five years, Net Margin topped out at 1737.12% in Q4 2024 and bottomed at 8191.34% in Q2 2022.
- A 5-year average of 2026.85% and a median of 1516.12% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin sank 688458 bps — and 2023, when it soared 667522 bps.
- Roivant Sciences' Net Margin stood at 4792.99% in 2020, then jumped by 71 bps to 1373.78% in 2021, then plunged by 126 bps to 3110.55% in 2022, then jumped by 69 bps to 956.57% in 2023, then surged by 282 bps to 1737.12% in 2024.
- Business Quant data shows ROIV's Net Margin at 1737.12% in Q4 2024, 962.75% in Q3 2024, and 1115.06% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,737.12% |
| Sep 30, 2024 | -962.75% |
| Jun 30, 2024 | 1,115.06% |
| Dec 31, 2023 | -956.57% |
| Sep 30, 2023 | -2,360.22% |
| Jun 30, 2023 | -1,516.12% |
| Dec 31, 2022 | -3,110.55% |
| Sep 30, 2022 | -2,520.71% |
| Jun 30, 2022 | -8,191.34% |
| Dec 31, 2021 | -1,373.78% |
| Sep 30, 2021 | -1,613.21% |
| Jun 30, 2021 | -1,306.76% |
| Dec 31, 2020 | -4,792.99% |
| Sep 30, 2020 | -4,043.69% |
| Jun 30, 2020 | -506.15% |